Cargando…
Long‐term outcomes of heart failure patients who received primary prevention implantable cardioverter‐defibrillator: An observational study
BACKGROUND: Implantable cardioverter‐defibrillator (ICD) therapy is indicated for selected heart failure patients for the primary prevention of sudden cardiac death. Little is known about the outcomes in patients selected for primary prevention device therapy in the northern region of New Zealand. M...
Autores principales: | Looi, Khang‐Li, Sidhu, Karishma, Cooper, Lisa, Dawson, Liane, Slipper, Debbie, Gavin, Andrew, Lever, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828273/ https://www.ncbi.nlm.nih.gov/pubmed/29721113 http://dx.doi.org/10.1002/joa3.12027 |
Ejemplares similares
-
Utilization of cardiac resynchronization therapy in patients with heart failure in the Northern Region of New Zealand
por: Looi, Khang‐Li, et al.
Publicado: (2018) -
Implantable cardioverter-defibrillators /
Publicado: (1994) -
Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020) -
Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021) -
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)